| | Varia. | Varia. 5d. | Varia. 1 de ene. | Varia. 1 año | Varia. 3 años | Capi. (M$) |
 | ATEA PHARMACEUTICALS, INC. | 2.93% | 4.21% | -15.49% | -62.38% | --.--% | 629 |
| | | | | | | |
| GILEAD SCIENCES, INC. | -0.83% | 1.90% | -11.21% | -2.83% | -3.62% | 80 866 |
| REGENERON PHARMACEUTICALS, INC. | -1.08% | 4.00% | 8.22% | 37.47% | 118.66% | 73 638 |
| VERTEX PHARMACEUTICALS | -0.44% | 5.56% | 22.79% | 30.39% | 56.98% | 68 965 |
| BIONTECH SE | 2.25% | -5.79% | -38.65% | -21.85% | --.--% | 38 433 |
 | WUXI APPTEC CO., LTD. | -3.54% | -10.58% | -25.70% | -36.93% | 159.96% | 37 870 |
 | GENMAB A/S | -0.61% | -0.71% | -19.73% | -13.16% | 72.54% | 19 941 |
 | ARGENX SE | -0.03% | -1.77% | -6.85% | 30.71% | 142.13% | 17 213 |
| BEIGENE, LTD. | 3.02% | -0.31% | -51.55% | -62.15% | 3.67% | 13 543 |
| NEUROCRINE BIOSCIENCES, INC. | 1.65% | 5.24% | 5.48% | -6.72% | 12.45% | 8 587 |
| HALOZYME THERAPEUTICS, INC. | 0.67% | 6.30% | 15.89% | 10.95% | 202.40% | 6 420 |
| SAREPTA THERAPEUTICS, INC. | 3.52% | 2.43% | -21.27% | -5.40% | -41.33% | 6 204 |
| LEGEND BIOTECH CORPORATION | 0.49% | -5.23% | -15.58% | 4.82% | --.--% | 6 069 |
| EXELIXIS, INC. | 2.13% | 4.30% | -0.49% | -18.79% | -10.66% | 5 834 |
| INTRA-CELLULAR THERAPIES, INC. | 3.62% | 1.71% | 12.19% | 49.53% | 335.93% | 5 539 |
 | BIOCON LIMITED | 0.91% | 0.90% | -9.95% | -14.02% | 19.20% | 4 984 |
| | | | | | | |
| | Promedio | 0.78% | 0.53% | -9.09% | -1.20% | 82.18% | |
| | Media ponderada por Capi. | -0.29% | 0.68% | -6.24% | 4.86% | 72.71% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
